Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A US Randomized Questionnaire-Based Trial Assessing The Impact Of The Availability Of Inhaled Insulin On Therapeutic Choice In Patients With Suboptimally Controlled Type 2 Diabetes

NCT00139763 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00139763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00139763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A US Randomized Questionnaire-Based Trial Assessing The Impact Of The Availability Of Inhaled Insulin On Therapeutic Choice In Patients With Suboptimally Controlled Type 2 Diabetes
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2005
Completion date
March 31, 2006
Enrollment
740
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2